Market Place
Sourcing Support
Zymeworks Appoints Leaders To Drive Growth Phase
09 Apr 2026 //
GLOBENEWSWIRE
Zymeworks Appoints Kristin Stafford As Chief Financial Officer
01 Apr 2026 //
GLOBENEWSWIRE
Zymeworks To Participate In Investor Conferences
24 Mar 2026 //
GLOBENEWSWIRE
Zymeworks, Royalty Pharma Secure $250M Royalty-Backed Note
02 Mar 2026 //
GLOBENEWSWIRE
Zymeworks Outlines Strategic Priorities And Outlook For 2026
11 Jan 2026 //
GLOBENEWSWIRE
Zymeworks Updates on First Quarter 2025 Financial Results
08 May 2025 //
GLOBENEWSWIRE
Zymeworks Presents New Data at 2025 AACR Annual Meeting
25 Apr 2025 //
GLOBENEWSWIRE
Zymeworks Appoints Dr. Sabeen Mekan as Senior VP
21 Apr 2025 //
GLOBENEWSWIRE
Zymeworks Achieves $14M Milestone from GSK Collaboration
26 Feb 2025 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
25 Feb 2025 //
GLOBENEWSWIRE
Zymeworks Announces Appointment of Oleg to Board of Directors
18 Feb 2025 //
GLOBENEWSWIRE
Zymeworks To Report Q4 & Full Year 2024 Financial Results
13 Feb 2025 //
GLOBENEWSWIRE
Zymeworks Shares Strategic Priorities & Outlook For 2025-2026
08 Jan 2025 //
GLOBENEWSWIRE
Zymeworks Announces $60M Share Repurchase Program
01 Aug 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
30 Jul 2024 //
GLOBENEWSWIRE
Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer
25 Jul 2024 //
GLOBENEWSWIRE
Zymeworks To Report Q2 2024 Results On August 1
11 Jul 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
28 May 2024 //
GLOBENEWSWIRE
Zymeworks Q1 2024 Results, Corporate Update
02 May 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
30 Apr 2024 //
GLOBENEWSWIRE
Zymeworks Q1 2024 Results, Call On 5/2
11 Apr 2024 //
GLOBENEWSWIRE
Zymeworks Presents Data from Multiple Preclinical Development Programs at AACR
08 Apr 2024 //
GLOBENEWSWIRE
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
28 Mar 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
27 Mar 2024 //
GLOBENEWSWIRE
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
06 Mar 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
27 Feb 2024 //
GLOBENEWSWIRE
Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
14 Feb 2024 //
GLOBENEWSWIRE
Zymeworks Announces Appointment of Dr. Alessandra Cesano to Board of Directors
08 Feb 2024 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
31 Jan 2024 //
GLOBENEWSWIRE
Zymeworks Announces Additional Leadership Appointments
04 Jan 2024 //
GLOBENEWSWIRE
Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025
04 Jan 2024 //
GLOBENEWSWIRE
Zymeworks Announces $50 Million Private Placement to EcoR1 Capital
26 Dec 2023 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conference
30 Nov 2023 //
GLOBENEWSWIRE
Zymeworks Reports Third Quarter 2023 Financial Results
07 Nov 2023 //
GLOBENEWSWIRE
Zymeworks To Host Third Quarter 2023 Results Conference Call
17 Oct 2023 //
GLOBENEWSWIRE
Zymeworks Announces New Director Nominee
16 Oct 2023 //
GLOBENEWSWIRE
Zymeworks Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
01 Aug 2023 //
GLOBENEWSWIRE
Zymeworks To Host Second Quarter 2023 Results Conference Call
19 Jul 2023 //
GLOBENEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conference
03 Jul 2023 //
GLOBENEWSWIRE
Zymeworks Appoints New Director
29 Jun 2023 //
GLOBENEWSWIRE
Zymeworks Set to Join Russell 3000®, Russell 2000, and Russell Microcap® Indexes
26 Jun 2023 //
GLOBENEWSWIRE
Zymeworks to open new EU HQ in Dublin, Ireland
22 Jun 2023 //
PHARMAFILE
Jazz and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO
02 Jun 2023 //
PR NEWSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
01 Jun 2023 //
GLOBENEWSWIRE
Zymeworks Announces Departure of Neil Klompas, President and COO
18 May 2023 //
GLOBENEWSWIRE
Zymeworks Provides Corporate Update and Reports 1Q 2023 FYR
08 May 2023 //
GLOBENEWSWIRE
Zymeworks Presents New Data from Multiple Preclinical and Clinical Development
18 Apr 2023 //
GLOBENEWSWIRE
Zymeworks Announces Appointment of Derek J. Miller to its Board of Directors
10 Apr 2023 //
BUSINESSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
03 Apr 2023 //
BUSINESSWIRE
Daiichi and Zymeworks end antibody pact after seven years
21 Mar 2023 //
ENDPTS
Zymeworks to Present Data on Multiple Product Candidates at AACR
14 Mar 2023 //
BUSINESSWIRE
Zymeworks Reports Fourth Quarter and Full Year 2022 Financial Results
07 Mar 2023 //
BUSINESSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
28 Feb 2023 //
BUSINESSWIRE
Zymeworks To Host Fourth Quarter And Full Year 2022 Results Conference Call
21 Feb 2023 //
BUSINESSWIRE
Zymeworks Announces Participation in Upcoming Investor Conferences
25 Jan 2023 //
BUSINESSWIRE
Zymeworks links HER2 bispecific to 84% survival at 18 months
20 Jan 2023 //
FIERCE BIOTECH
Zymeworks Provides Update on Key Strategic Priorities and Outlook for 2023
04 Jan 2023 //
BUSINESSWIRE
Zymeworks (ZYME) Stock Up 29% in Three Months: Here`s Why
28 Dec 2022 //
NASDAQ
Zymeworks Announces Participation in Upcoming Investor Conference
21 Dec 2022 //
BUSINESSWIRE
